Table 3.
Compound | R2 | Analytical Range (ng/mL) |
LOD (SM) (ng/mL) |
LOQ (SM) (ng/mL) |
LOD (PBS) (ng/mL) |
LOQ (PBS) (ng/mL) |
---|---|---|---|---|---|---|
AEA | 0.9960 | 0.1–2.5 | 0.013 | 0.045 | 0.027 | 0.088 |
2AG | 0.9918 | 0.1–2.5 | 0.004 | 0.015 | 0.027 | 0.089 |
2AGE | 0.9986 | 0.1–2.5 | 0.008 | 0.026 | 0.015 | 0.049 |
LNEA | 0.9965 | 0.1–2.5 | 0.033 | 0.109 | 0.019 | 0.064 |
LEA | 0.9916 | 0.1–2.5 | 0.030 | 0.100 | 0.028 | 0.094 |
PEA | 0.9954 | 0.1–2.5 | 0.030 | 0.101 | 0.027 | 0.090 |
OEA | 0.9998 | 0.1–2.5 | 0.020 | 0.076 | 0.025 | 0.084 |
SEA | 0.9999 | 0.1–2.5 | 0.005 | 0.018 | 0.013 | 0.045 |
DHEA | 0.9964 | 0.1–2.5 | 0.020 | 0.081 | 0.028 | 0.092 |
EPEA | 0.9982 | 0.1–2.5 | 0.010 | 0.033 | 0.005 | 0.017 |
ADA | 0.9980 | 0.1–2.5 | 0.018 | 0.059 | 0.029 | 0.099 |
ODA | 0.9998 | 0.1–2.5 | 0.031 | 0.106 | 0.029 | 0.099 |
ASer | 0.9959 | 0.1–2.5 | 0.019 | 0.064 | 0.023 | 0.081 |
AGly | 0.9998 | 0.1–2.5 | 0.030 | 0.101 | 0.029 | 0.099 |
OGly | 0.9985 | 0.1–2.5 | 0.028 | 0.094 | 0.035 | 0.100 |
PalGly | 0.9999 | 0.1–2.5 | 0.006 | 0.019 | 0.026 | 0.099 |
AGABA | 0.9988 | 0.1–2.5 | 0.021 | 0.084 | 0.017 | 0.057 |
A5HT | 0.9982 | 0.1–2.5 | 0.008 | 0.028 | 0.007 | 0.024 |
O5HT | 0.9942 | 0.1–2.5 | 0.002 | 0.073 | 0.013 | 0.043 |
Pal5HT | 0.9980 | 0.1–2.5 | 0.007 | 0.023 | 0.012 | 0.042 |
Abbreviations: arachidonoylethanolamide (AEA), N-linolenoylethanolamide (LNEA), N-linoleoylethanolamide (LEA), N-oleoylethanolamide (OEA), N-palmitoylethanolammide (PEA), N-stearoylethanolamide (SEA), N-docosahexaenoylethanolamide (DHEA), N-eicosapentaenoylethanolamide (EPEA), N-arachidonoyldopamine (ADA), N-oleoyldopamine (ODA), N-arachidonoylglycine (AGly), N-oleoylglycine (OGly), N-palmitoylglicine (PalGly), N-arachidonoylserine (ASer), N-arachidonoylserotonine (A5HT), N-oleoylserotonine (O5HT), N-palmitoylserotonine (Pal5HT), 2-arachidonoylglycerylether (2AGE), 2-arachidonoyglycerol (2AG), N-arachidonoyl-3-hydroxy-γ-aminobutyric acid (AGABA).